(2R)-2-[(1S)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]-N-isopropyl-2-phenylacetamide

(2R)-2-[(1S)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydro-2(1H)-isochinolinyl]-N-isopropyl-2-phenylacetamid

(2R)-2-[(1S)-1-(3,4-Diméthoxybenzyl)-6,7-diméthoxy-3,4-dihydro-2(1H)-isoquinoléinyl]-N-isopropyl-2-phénylacétamide

(2R)-2-[(1S)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl]-N-isopropyl-2-phenylacetamide

2(1H)-Isoquinolineacetamide, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-N-(1-methylethyl)-alpha-phenyl-, (alphaR,1S)-

(2R)-2-[(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-2-phenyl-N-propan-2-ylacetamide

(2R)-2-[(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-N-isopropyl-2-phenyl-acetamide

(R)-2-((S)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-N-isopropyl-2-phenylacetamide

1354039-86-3

compound 9 [PMID: 23589487]

MFCD27991288

Orexin receptor type 2

Orexin/Hypocretin receptor type 1

OX1R_HUMAN

OX2R_HUMAN